Pittsburgh Business Times- UPMC Enterprises, the medical technology investment arm of UPMC, has purchased interest in RxAnte, a company that uses analytics to predict how patients will adhere to the medications they’re prescribed.
RxAnte will continue to operate as an independent company, and the investment from UPMC Enterprises will allow it to expand its offerings for Medicare, Medicaid and commercial populations, and to extend its predictive models and workflow tools to high-cost specialty drugs.
Are current health care reforms finally changing the game for remote patient monitoring?
New CPT Code a Step in the Right Direction for Utilizing Remote Monitoring to Bridge …
Alissa Meade, CEO of Curavi Health, on the power of asking for opportunity
There was only so much time to answer audience questions during a panel discussion on leadership and mentoring last month at UPMC Enterprises. So, we’ve tapped the panelists to share their thoughts on questions that were submitted but unanswered.